The protective effects and underlying mechanisms of dapagliflozin on diabetes-induced testicular dysfunction.
Ontology highlight
ABSTRACT: Male diabetic individuals present a marked impairment in fertility; however, knowledge regarding the pathogenic mechanisms and therapeutic strategies is unsatisfactory. The new hypoglycemic drug dapagliflozin has shown certain benefits, such as decreasing the risk of cardiovascular and renal events in patients with diabetes. Even so, until now, the effects and underlying mechanisms of dapagliflozin on diabetic male infertility have awaited clarification. Here, we found that dapagliflozin lowered blood glucose levels, alleviated seminiferous tubule destruction, and increased sperm concentrations and motility in leptin receptor-deficient diabetic db/db mice. Moreover, the glucagon-like peptide-1 receptor (GLP-1R) antagonist exendin (9-39) had no effect on glucose levels but reversed the prot
SUBMITTER: Luo ZC
PROVIDER: S-EPMC10226494 | biostudies-literature | 2023 May-Jun
REPOSITORIES: biostudies-literature
ACCESS DATA